Current Issue

March 2015

NASH on the rise as cause of liver transplant
Since 2004, there’s been almost a tripling of the number of nonalcoholic steatohepatitis patients waiting for liver transplants; the condition is now the second-leading reason to be put on the waiting list in the United States, according a study published in Gastroenterology.

CNS stimulant is first drug approved for binge eating
Lisdexamfetamine, the central nervous system stimulant marketed as Vyvanse, has been approved for treating binge-eating disorder in adults and is the first drug approved for this indication, the Food and Drug Administration has announced.

ABIM responds to criticism, apologizes
In a frank announcement, the American Board of Internal Medicine has apologized to doctors for a Maintenance of Certification program that “clearly got it wrong,” and pledged to make the program more consistent with internists’ practice and values.

Updated HIV, HCV, HBV blood product screening test
An updated version of a blood screening assay that detects human immunodeficiency virus type 1 (HIV-1), hepatitis C virus (HCV), and hepatitis B virus (HBV) in donated blood has been  approved by the Food and Drug Administration, the manufacturer, Roche, recently announced.

Lawmakers, experts favor October start for ICD-10
The transition to the ICD-10 coding set should take place as planned on Oct. 1, witnesses testified at a hearing of the House Energy and Commerce Committee’s Subcommittee on Health.

PDF | Interactive Version